Biotech Values

[DewDiligence]

If I had my druthers, MNTA would have partnered with PFE or SNY rather than BAX. Moreover, I would have preferred to see MNTA ink more lucrative terms in a deal for one or two FoB’s rather than a somewhat less lucrative deal that incorporates as many as six FoB’s and has a large number of moving parts. However, it does not follow from the above that I think MNTA got “screwed,” which seems to be the point you’ve been pressing for the past 26 hours.